JETEMA, Co., Ltd.

KOSDAQ 216080.KQ

JETEMA, Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 54.92 M

JETEMA, Co., Ltd. Shareholders' Equity is USD 54.92 M for the year ending December 31, 2023, a 22.08% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • JETEMA, Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 44.99 M, a -1.49% change year over year.
  • JETEMA, Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 45.67 M, a 19.69% change year over year.
  • JETEMA, Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 38.16 M, a 30.43% change year over year.
  • JETEMA, Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 29.25 M, a 748.67% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
SV Wall Street
KOSDAQ: 216080.KQ

JETEMA, Co., Ltd.

CEO Jeong Sun Nam
IPO Date Nov. 14, 2019
Location South Korea
Headquarters 1283-4, Gagok-ri
Employees 227
Sector Healthcare
Industries
Biotechnology 3D Printing Cosmetics Dental Care Eyewear Personal Care Pharmaceuticals Plastics
Description

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. The company is headquartered in Wonju, South Korea.

StockViz Staff

February 4, 2025

Any question? Send us an email